, Volume 45, Supplement 3, pp 225–226 | Cite as

Clinical Trial of Sparfloxacin in the Treatment of Leprosy

  • Scott G. Franzblau
  • Gertrude P. Chan
Poster Presentations Quinolone Activity against Intracellular Pathogens Including Mycobacteria


Ofloxacin Leprosy Baton Rouge Pefloxacin Sparfloxacin 


  1. Franzblau SG, Biswas AN, Jenner P, Colston MJ. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents. Leprosy Review 63: 125–133, 1992PubMedGoogle Scholar
  2. Franzblau SG, White KE. Comparative in vitro activity of 20 fluoroquinolones against Mycobacterium leprae. Antimicrobial Agents and Chemotherapy 34: 229–231, 1990PubMedCrossRefGoogle Scholar
  3. Grosset JH, Guelpa-Lauras CC, Perani EG, N’Deli LN. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. International Journal of Leprosy 58: 281–295, 1990Google Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • Scott G. Franzblau
    • 1
  • Gertrude P. Chan
    • 2
  1. 1.GWL Hansen’s Disease Laboratory Research BranchBaton RougeUSA
  2. 2.Research Institute for Tropical MedicineMetro ManilaPhilippines

Personalised recommendations